Combination of Magnesium and Lidocaine for the Pretreatment of Pain That is Caused by the Injection of Propofol
NCT01342510 is a phase 4 interventional trial sponsored by University of Wisconsin, Madison. As of 18 Nov 2026, it is completed. It studies Control, Lidocaine and Magnesium sulfate in General Anesthesia and Intravenous Anesthesia. The registry lists an enrollment of 200 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2011 and a primary completion date of 30 Apr 2012.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01342510 |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | University of Wisconsin, Madison |
| Enrollment | 200 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | General Anesthesia and Intravenous Anesthesia |
| Drugs | Control, Lidocaine and Magnesium sulfate |
| Start | 30 Apr 2011 |
| Primary completion | 30 Apr 2012 |
| Study completion | 30 Apr 2012 |
| Last update posted | 29 May 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Kristopher M Schroeder, MD
University of Wisconsin, Madison
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Wisconsin Hospital and Clinics
Madison
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT01342510
Each answer restates registry values shown on this page.
What is NCT01342510?
NCT01342510 is a phase 4 interventional trial sponsored by University of Wisconsin, Madison. It studies Control, Lidocaine and Magnesium sulfate in General Anesthesia and Intravenous Anesthesia.
Who leads NCT01342510?
The registry names Kristopher M Schroeder, MD (principal investigator, University of Wisconsin, Madison) as the overall official.
Where does NCT01342510 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT01342510 study?
The registered drug and biological interventions are Control, Lidocaine and Magnesium sulfate.
When did NCT01342510 end?
The registry lists a primary completion date of 30 Apr 2012 and a study completion date of 30 Apr 2012. The sponsor last updated the record on 29 May 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.